Trial Profile
Effects of Glucagon Like Peptide-1 on No-reflow in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 05 Jul 2017 New trial record